Proactive research analyst Robin Davison speaks to Thomas Warner after publishing a new research note on commercial-stage specialty pharmaceutical company.
Proactive research analyst Robin Davison speaks to Thomas Warner after publishing a new research note on commercial-stage specialty pharmaceutical company.
Shield Therapeutics PLC (AIM:STX, OTCQX:SHIEF) said it is "very" optimistic about the future as it gears up for a full US commercial push of its lead asset,.